That’s the title of a free public talk on vaccines being held at the University of Alberta next week.
The talk will host two distinguished and influential speakers on the topic: Dr. David Evans, virologist and vice-dean (research) for the Faculty of Medicine & Dentistry and Dr. Ubaka Ogbogu, assistant professor at the Faculty of Law and Pharmacy and Pharmaceutical Sciences at the University of Alberta.
They will tackle commonly asked questions and talk about the basic science behind vaccines, with a focus on making the information understandable. The talk will be interactive, with audience participation and a question and answer session.
The public talk is being held at the Edmonton Clinic Health Academy, room 2-190, from 7 p.m. to 8:30 p.m. on Tuesday.
The University of Calgary is looking to recruit Alberta seniors with, or at risk of, cardiovascular disease for a new study on increasing accessibility to preventative medication.
The study is looking to determine if interventions, such as providing free preventative medications and/or a personalized education program that helps patients better connect with their pharmacist and physician, will help offset financial and knowledge barriers faced by many Alberta seniors.
According to the university, up to 50 per cent of Albertans at high risk of heart disease do not receive the cholesterol-lowering drugs and are at greater risk of heart attacks, strokes and other complications. The most common barriers are financial and knowledge-based.
The randomized control trial is looking to recruit 5,000 Albertan seniors (over the age of 65), who have an annual income of less than $50,000 and are at high risk of cardiovascular events.
To be eligible participants must have had a previous heart attack, stroke or heart failure, suffer from chronic kidney disease, or have any two of the following: diabetes, high blood pressure, high cholesterol or be a current cigarette smoker (greater than half a pack per day.)
Participants have a 50 per cent chance of receiving free preventative medications for diabetes, high blood pressure, heart disease, blood thinners and medications to stop smoking for the three-year duration of the study.
Those interested should call the study team at 1-844-944-8927 or email email@example.com.